# Attenuation Of Hemodynamic Response To Laryngoscopy. Role Of Dexmedetomidine. A Dose Finding Study

> **NCT05909215** · PHASE4 · COMPLETED · sponsor: **Sindh Institute of Urology and Transplantation** · enrollment: 105 (actual)

## Conditions studied

- Hemodynamic Instability
- Tracheal Intubation
- Dexmedetomidine

## Interventions

- **DRUG:** Normal saline
- **DRUG:** Dexmedetomidine 0.5 microgram/kg
- **DRUG:** Dexmedetomidine 0.75 microgram/kg

## Key facts

- **NCT ID:** NCT05909215
- **Lead sponsor:** Sindh Institute of Urology and Transplantation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-23
- **Primary completion:** 2021-12-13
- **Final completion:** 2021-12-13
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2023-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05909215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05909215, "Attenuation Of Hemodynamic Response To Laryngoscopy. Role Of Dexmedetomidine. A Dose Finding Study". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05909215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*